Re: Valneva vaccine
Posted 7/22/2021 9:14:45 PM by GoldenRod

https://valneva.com/research-development/covid-19-vla2001/


What is VLA2001 and how is it different from other approaches?
VLA2001 is a Vero-cell based, highly-purified inactivated whole virus vaccine candidate.
VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe.
The inactivated vaccine is a proven approach that has been used for decades. [1]
An inactivated SARS-CoV-2 vaccine is expected to be suitable for wide deployment.
Valneva’s vaccine candidate is based on the same manufacturing platform the Company already uses to produce its FDA/EMA/MHRA approved JE vaccine.
VLA2001 combined with alum and Dynavax’s adjuvant CpG 1018 has been demonstrated in preclinical studies and as confirmed by recently obtained initial Phase 1/2 clinical data to induce a strong immune response and has the potential to generate high titers of neutralizing antibodies.
Valneva’s inactivated SARS-CoV-2 vaccine is expected to have a two-dose regimen.
VLA2001 is expected to conform with standard cold chain requirements (2 degrees to 8 degrees centigrade).


Print Post      Close Window